Compare Regeneron Pharmaceuticals Inc (REGN) vs Direxion Daily Semiconductor Bear 3X Shares (SOXS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Regeneron Pharmaceuticals Inc vs Direxion Daily Semiconductor Bear 3X Shares — how do they compare? Regeneron Pharmaceuticals Inc trades at $807.6 (market cap $83.43B), while Direxion Daily Semiconductor Bear 3X Shares trades at $43.9. The key difference: Regeneron Pharmaceuticals Inc pays a 0.46% dividend while Direxion Daily Semiconductor Bear 3X Shares pays none. Which is the better fit depends on your goals.
| REGN | SOXS | |
|---|---|---|
Market Cap | $83.43B | — |
Sector | Health | Leveraged / Inverse |
52-Week High | $852.03 | $1.29K |
52-Week Low | $555.51 | $32.50 |
Enterprise Value | $78.14B | — |
Dividend Yield | 0.46% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Regeneron Pharmaceuticals (REGN) trades at $810.31, down 2.1% today, with strong fundamentals including 84.9% gross margins and consistent earnings beats. The stock shows bullish technical signals with support at $805 and resistance at $838, while analyst consensus remains strongly positive with 69% buy ratings. Recent news highlights multiple class action lawsuits related to clinical trial disclosures, creating near-term sentiment headwinds despite solid financial performance.
Outlook remains cautiously optimistic given strong profitability and analyst support, though legal risks and clinical trial uncertainties present challenges. The stock trades above consensus price target of $756.82, suggesting limited near-term upside potential despite robust fundamentals and institutional confidence.
SOXS, the Direxion Daily Semiconductor Bear 3X ETF, declined 4.86% to $44.09 amid bearish technical signals with 18 sell indicators versus 2 buy signals. The fund benefits from semiconductor sector weakness but faces volatility due to its leveraged inverse structure. Recent corporate actions include a 1:10 stock split scheduled for July 2026 and a $0.04 dividend payment in June 2026.
The outlook remains challenging with technical indicators signaling bearish momentum. While SOXS offers tactical opportunities during semiconductor downturns, its leveraged nature poses significant risks for long-term investors. Key risks include AI hardware demand resilience and rapid market reversals that could erode value quickly.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Regeneron Pharmaceuticals Inc
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases
Read more on REGN →About Direxion Daily Semiconductor Bear 3X Shares
SOXS is a leveraged ETF that seeks daily investment results corresponding to 300% of the inverse (opposite) of the daily performance of the ICE Semiconductor Index. It is designed as a tactical tool for experienced traders to take a bearish (short) position on the semiconductor sector. Due to the effects of compounding and leverage, SOXS is intended to be held for a single day and is not suitable for long-term investment.
Read more on SOXS →
